# Processa Pharmaceuticals, Inc.: Form 8-K, filed Jun 21, 2013

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: 8-K
- Filed: 2013-06-21
- Accepted by EDGAR: Jun 21, 2013, 15:58 ET
- Period: 2013-06-20
- Accession: 0001393905-13-000318
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000139390513000318/hwux_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000139390513000318/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 5.02: Departure or appointment of officers or directors
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000139390513000318/hwux_8k.htm

Filed Jun 21, 2013.
Source: SEC EDGAR, the filing index for accession 0001393905-13-000318. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
